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Tumors that arise from the endocrine pancreas, or the islets of pancreas, are called pancreatic neuroendocrine tumors 
(NETs). Pancreatic NET have an incidence of ＜0.1 per one million persons, and can lead to secretion of ectopic 
adrenocorticotropic hormone (ACTH). Herein, we presented a case of patient with Cushing’s syndrome as a result 
of ACTH-producing pancreatic NET, who underwent successful laparoscopic distal pancreatosplenectomy. A 
40-year-old Korean female patient with ophthalmologic discomfort, osteoporosis, and unexplained hypokalemia was 
admitted to our hospital. Under the suspicion of ACTH producing pancreatic NET after the diagnostic workup, we de-
cided to perform surgical resection. Laparoscopic distal pancreatosplenectomy was performed; and the pathological 
examination revealed a 1.5 cm-sized grade 2 neuroendocrine tumor of the pancreas, which was encapsulated within 
the pancreatic parenchyma. After the operation, the patient no longer displayed cushingoid features. ACTH-producing 
pancreatic NET is rare, but can be one of the causes of Cushing’s syndrome. Surgical resection is a feasible option 
in treating ACTH-producing pancreatic NET. (Ann Hepatobiliary Pancreat Surg 2017;21:61-65)
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INTRODUCTION
Tumors that arise from the endocrine pancreas, or the 
islets of pancreas, are called pancreatic neuroendocrine tu-
mors (NETs). NETs account for 1-3% of pancreatic tu-
mors; however, the incidence of NETs is reported to be 
on the rise.1,2 The most well-known functional NETs in-
clude gastrinoma, insulinoma, glucagonoma, somatostati-
noma, and vasoactive intestinal peptide tumor (VIPoma). 
However, NETs that produce ACTH have been reported, 
despite their lower prevalence than the other types of 
functional tumors.3
Uncontrolled production of ACTH can lead to the in-
crease in glucocorticoid level, resulting in Cushing’s 
syndrome. More than 80% of Cushing’s syndrome is asso-
ciated with autonomous pituitary ACTH secretion; how-
ever, it is well documented that approximately 4-18% of 
Cushing’s syndrome is due to ectopic ACTH secretion.4 
Pancreatic NET has an incidence of <0.1 per one million 
persons, and can lead to ectopic ACTH secretion.5 In a 
review of 42 select cases of islet tumor, Clark et al.6 re-
ported that two-thirds of the patients presented with 
weight gain, acne, diabetes mellitus, and hypokalemic 
alkalosis. In Korea, Song et al.7 previously reported a 
52-year-old male patient with ACTH-producing pancreatic 
NET accompanying multiple liver metastases. However, 
the study was limited to understanding the natural courses 
of the tumor biology. Herein, we presented a case of a 
patient with Cushing’s syndrome as a result of 
ACTH-producing pancreatic NET, who underwent suc-
cessful laparoscopic distal pancreatosplenectomy, with a 
brief review of the relevant literature.
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Fig. 1. Patient follow-up. (A) Preoperation, (B) Postoperation,
(C) ACTH and cortisol.
CASE
A 40-year-old Korean female patient with ophthalmo-
logic discomfort, osteoporosis, and unexplained hypo-
kalemia was admitted. She had undergone ptosis surgery 
multiple times due to discomfort in the eyes (three times 
in 2010 and four times in January of 2015). She had no 
reported use of steroid other than one time in March of 
2015 for eye discomfort. However, the patient started to 
display prominent cushingoid appearance including 
moon-face, extremity weakness, amenorrhea, pene-
trative-looking skin, easy bruising, and buffalo-hump (Fig. 
1A).
In laboratory workup, elevated serum ACTH at 108.6 
pg/ml (normal range: 7.2-63.3 pg/ml) and urinary free 
cortisol at 721.6 g/day (normal range: 20-90 g/day) 
were noted. In addition, serum cortisol was elevated at 
29.3 g/dl (Fig. 1C). Cortisol level was not suppressed 
with high-dose dexamethasone suppression test. Sella 
MRI revealed no abnormal signal intensity or abnormal 
mass lesion. Abdomen-pelvis computerized tomography 
(CT) showed no mass lesions in the abdominal organs 
(Fig. 2A). However, endoscopic ultrasonography (EUS) 
confirmed a hypoechoic, homogenous, solid mass with 
size of 1.8 cm in the pancreatic tail (Fig. 2B). In addition, 
PET revealed a low-density lesion at the pancreatic tail 
showing prominent FDG uptake (Fig. 2C). Under the sus-
picion of ACTH producing pancreatic NET, venous sam-
pling was performed to verify autonomous hormone 
production. ACTH was measured from six different 
locations. At all locations, the ACTH level was above 
normal (Fig. 2D). Therefore, we decided to perform surgi-
cal resection. Laparoscopic distal pancreatosplenectomy 
using modified lasso technique, which includes isolation 
and ligation of the splenic artery prior to lasso technique, 
was performed.8 The operation time was approximately 90 
mins. The patient was transferred to the department of en-
docrinology for close monitoring of the hormonal status 
on postoperative 7th day with no clinically relevant 
complications. The pathological examination revealed a 
1.5 cm-sized grade 2 neuroendocrine tumor of the pan-
creas, which was encapsulated within the pancreatic pa-
renchyma (Fig. 3A). No lymph node metastasis was noted 
(pT1N0M0). The resection margin was free from tumor. 
Tumor cells were strongly positive for chromogranin A, 
synpatophysin, and ACTH in (Fig. 3B-D).
The serum ACTH and cortisol values were restored to 
the normal cut-off values immediately after the surgical 
removal of the neuroendocrine tumor (Fig. 1C). In corre-
lation with the decreased cortisol level, the patient no lon-
ger displayed cushingoid features; and central obesity and 
the moon-face characteristic were improved significantly 
(Fig. 1B).
DISCUSSION
Due to the rarity of ACTH-producing pancreatic NETs 
and difficulty of performing curative resection, only a few 
cases have been reported.3,6 In our patient, surgical re-
moval of the functioning NET of the pancreas alleviated 
most of the symptoms associated with Cushing’s 
syndrome. Most notably, the ACTH and cortisol level 
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Fig. 2. Preoperative findings. (A) Adrenal Computed Tomography: No remarkable finding in both adrenal glands. (B) Endoscopic
ultrasonography: 18 mm-sized solid mass was localized to the pancreatic tail. Echo intensity was hypoechoic and echo texture
was homogenous (black arrows). (C) Uptake at the pancreatic tail in positron emission tomography (white arrows). (D) ACTH
sampling from the pancreatic, splenic, and portal vein.
Fig. 3. Postoperative findings. (A) Gross specimen, (B) Ki-67, (C) Chromogranin A, (D) Synaptophysin, and (E) ACTH (×100).
dropped almost immediately after the resection of the 
tumor. We summarized similar cases that have been pre-
viously reported in the literature (Table 1).
Herein, we showed five selected patients from Clark’s 
review of 42 patients with islet tumor.6 Of the 42 cases, 
most of the patients (64%) were women with the mean 
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Table 1. Characteristics of the present case and select reported cases
#1† #23 #3-76
Age 40 65 45 31 22 52 61
Gender F F F F F F F
Clinical 
symptoms
Cushing’s Jaundice, 
Cushing’s
Cushing’s Cushing’s Cushing’s Cushing’s Cushing’s
ACTH level 
(pg/ml)
108.6 228.4 580-1160 N/A 480 N/A N/A
Cortisol level 
(g/dl)
29.3 21.3 39 80 17 21.5 27.8
Location Pancreatic 
tail
Pancreatic 
tail
Metastatic 
ICT
Metastatic 
ICT
Metastatic 
ICT
ICT Metastatic 
ICT
Tumor size 1.4 cm 1.5 cm N/A N/A N/A N/A N/A
Follow up 8 months N/A 33 months 20 months 20 years 17 years 4 days
Recurrence No N/A N/A N/A Liver N/A N/A
Survival Alive N/A Expired Expired Alive Expired Expired
†Our case. ACTH, adrenocorticotropic hormone; ICT, islet cell tumor; N/A, not available
age of 39.8 years, and 66% of the patients initially pre-
sented with cushingoid features. Metastases occurred in 
88% of the patients and 60% were dead in ≤24 months. 
These results emphasize the aggressive nature of ACTH- 
producing islet cell tumors.
Marcos and Lila3 reported a case of a 65-year old 
Caucasian female patient with ectopic ACTH neuro-
endocrine tumor of the pancreas who presented with facial 
swelling, weight gain, as well as increased facial hair. 
Abdominal CT revealed a calcified mass of approximately 
1.5 cm2 within the pancreatic tail. Patient’s initial ACTH 
and cortisol levels were elevated (228.4 pg/ml and 21.3 
g/dl, respectively). Laparoscopic distal pancreatectomy 
was performed. Subsequent pathology revealed neuro-
endocrine carcinoma. Post-surgery, the ACTH and cortisol 
levels returned to normal and the patients’ symptoms 
subsided. This case demonstrates the importance and bene-
fits of laparoscopic resection.
However, such surgical resection has not been con-
ducted previously in Korea. To our best knowledge, this 
report is the first case of successfully treated Cushing’s 
syndrome due to pancreatic neuroendocrine tumor produc-
ing autonomous ACTH via laparoscopic distal pan-
creatosplenectomy in Korea. Prior to our case, a 
72-year-old woman with a history of general weakness 
was diagnosed with elevated serum cortisol level of 120 
g/dl. Abdominal CT revealed hypovascular masses in the 
pancreas. However, due to the patient’s general weakness 
and old age, neither the biopsy nor the surgery was 
performed.9
The reported cases collectively suggest that most pa-
tients with pancreatic ACTH-producing pancreatic NET 
were females and initially presented with cushingoid fea-
tures; however, further analysis is required to confirm 
these findings. As previously reported, the 5-year survival 
rate of patients with pancreatic islet cell tumor and 
Cushing’s syndrome is 16% with frequent metastases.6 
Consequently, patient’s progress must be closely moni-
tored even after surgical removal. At the three-month fol-
low-up post-surgery, our patient showed no symptoms of 
such manifestations. Currently, there is no unified treat-
ment algorithm after curative resection. Therefore, fol-
low-up study of our case will be helpful in understanding 
the natural course of resected ACTH-producing NET of 
the pancreas.
In summary, ACTH-producing pancreatic NET is rare, 
but can be one of the causes of Cushing’s syndrome. 
Based on the literature review, curative resection is diffi-
cult because of concomitant multiple liver metastases, and 
a significant number of cases are associated with lymph 
node metastasis; however, laparoscopic distal pan-
creatosplenectomy can be one of the options in treating 
left-sided ACTH-producing pancreatic NET.
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